CD44 and lung cancer: TIPRL expression was significantly increased in CSCs isolated from lung cancer cell lines using cluster of differentiation (CD)133 and CD44 antibodies, compared to non‐CSCs (Figure 1D,E; Figure S2A, Supporting Information).